Government officials, global health leaders, clinicians, patient advocates, professional societies and industry partners recently gathered during United Nations (UN) General Assembly Week (18–28 September 2026, New York, USA) for a meeting titled, ‘From resolution to action: investing in acute stroke care’, which focused on translating global commitments on stroke into concrete improvements in prevention, acute treatment, rehabilitation, and access to care.
The 22 September reception was convened through the Society of Vascular and Interventional Neurology’s (SVIN) Mission Thrombectomy in partnership with the Business Council for International Understanding (BCIU), Philips, and Medtronic Neurovascular.
The event brought together representatives from international cardiovascular, stroke, neurointerventional and neurosurgical organisations, including the American Heart Association (AHA), World Stroke Organization (WSO), World Federation of Interventional and Therapeutic Neuroradiology (WFITN), Society of NeuroInterventional Surgery (SNIS), and International Society for Global Neurosurgery (ISGNS), alongside ministries of health and other global health stakeholders. Together, these entities brought perspectives spanning public health, stroke systems, neurointervention, global neurosurgery, policy and implementation, as noted in an SVIN press release.
The release adds that this gathering came at “a pivotal moment for global stroke policy”; WHA79.10, adopted by the World Health Assembly in May 2026, represents a “landmark global commitment” to addressing stroke comprehensively, covering prevention, acute care, rehabilitation, and health-system readiness.
WHA79.10 was championed by the Egyptian Ministry of Health and Population with support from the Global Stroke Action Coalition (GSAC)—which comprises organisations and industry leaders dedicated to advancing stroke prevention, treatment, rehabilitation, and access to care worldwide. The resolution represents an “important example” of how governments, professional organisations, patient advocates and industry “can work together to elevate stroke on the global health agenda”, the SVIN release also states.
Debates during UN General Assembly Week
Discussions centred on a fundamental challenge: scientific advances have made highly effective stroke treatments possible, including mechanical thrombectomy for large vessel occlusion (LVO), but millions of eligible patients worldwide still cannot access these treatments in a timely manner.
The conversation was opened by Fawaz Al-Mufti (New York Medical College, New York, USA), global chair of SVIN’s Mission Thrombectomy, who shared ‘the clinical and economic case for acute stroke treatment’, highlighting the “extraordinary effectiveness” of mechanical thrombectomy for eligible patients with LVO stroke. Drawing on global data and an economic analysis spanning six countries, Al-Mufti emphasised that investing in access to thrombectomy can represent a fraction of the societal cost associated with stroke-related disability.
“We are already paying for stroke,” he commented. “The question is whether we choose to pay for recovery today or disability for years to come. A timely thrombectomy can offset a lifetime of disability and its associated costs. We need to stop viewing thrombectomy simply as a procedural expense and recognise access to effective stroke treatment as an investment in people, families, and national capacity.”
The patient perspective was then brought into focus by Margaret O’Neil Wheeler, who shared “a moving account of resilience and fortitude” following an LVO stroke. Accompanied by her husband, whose prompt recognition and action helped get her to lifesaving care in time, Wheeler was reunited at the event with Al-Mufti—who performed her emergency thrombectomy at Westchester Medical Center (New York, USA). Their reunion offered a “powerful reminder” of what timely access to advanced stroke care can mean: not simply survival, but recovery, independence, and the opportunity to return to life after stroke.
Dileep Yavagal (University of Miami, Coral Gables, USA), founder and global chair emeritus of SVIN’s Mission Thrombectomy, followed this with a presentation titled, ‘From global advocacy to global action’. Yavagal described stroke as a “long-neglected pandemic” and emphasised that solving the global access gap requires more than simply building additional thrombectomy centres. Sustainable systems require public and prehospital education, government advocacy, technology, financing, trained teams, and implementation strategies tailored to individual countries, he added.
“We have crossed the scientific frontier—we know thrombectomy can profoundly alter the course of a devastating stroke,” Yavagal commented. “The frontier before us now is access.”
Clinician, industry and health-policy voices
“Stroke does not respect borders, and access to lifesaving treatment should not be determined by where a patient lives,” stated SVIN president Santiago Ortega-Gutierrez (University of Iowa, Iowa City, USA). “The science is clear, the therapies exist, and the global community has recognised stroke as an urgent health priority. Our responsibility now is to turn that recognition into action. Through Mission Thrombectomy, SVIN is committed to measurable progress in access, treatment, and recovery, with the goal that every eligible patient has a meaningful opportunity to survive stroke without preventable disability.”
“Recognition is important, but ultimately our success will be measured by access,” added Mission Thrombectomy vice-chair Kaiz Asif (Endeavor Health, Chicago, USA). “Our goal is to translate this global momentum into a simple reality: that more patients, regardless of where they live, can reach lifesaving thrombectomy in time.”
“The science has given us the ability to dramatically change the outcome of a devastating stroke. The next challenge is ensuring that this opportunity is not defined by geography or resources. That will require sustained collaboration among clinicians, health systems, governments and communities to translate what we know into meaningful access for patients worldwide,” commented SVIN president-elect Robin Novakovic-White (UT Southwestern Medical Center, Dallas, USA).
The proceedings during the UN’s General Assembly Week also aw industry partners underscore the fact that innovation must be accompanied by the systems required to deliver treatment.
“Innovation alone is not enough,” said Signe Haughton, senior director of medical, government and societal affairs, and chief of staff, at Medtronic Neurovascular. “Devices and therapies make a meaningful difference only when patients can reach the right facility, receive timely diagnosis, and be treated by trained teams within an integrated system of care.”
“For people experiencing stroke, every minute matters,” added Felipe Basso, chief executive officer, Latin America, Philips. “Better-connected data, technologies and clinical workflows can help healthcare professionals make timely decisions, support rapid diagnosis and appropriate treatment, and expand access to the right care when patients need it most.”
Finally, Mohamed Fawzi—radiology advisor to the minister of health and population in the Arab Republic of Egypt’s Ministry of Health and Population—provided a country-specific perspective on building a national stroke system.
Egypt’s progress includes 206 stroke units and centres—58 certified through the General Authority for Healthcare Accreditation and Regulation (GAHAR)—free thrombolysis, reimbursement for thrombectomy, approval of tenecteplase, and a prehospital hotline linking approximately 100 hospitals. A national electronic stroke registry is also being launched, with plans to expand the network to 440 units, strengthen certification, establish a national rehabilitation pathway, and publish national treatment rates and treatment times.
According to the SVIN’s press release, the message emerging from the convening was clear: a resolution creates momentum; implementation is what changes outcomes for patients.
“The science exists. The therapies exist. The opportunity now is to build the systems that ensure every eligible patient—regardless of geography or resources—can reach lifesaving stroke treatment in time,” the release adds.
